These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16271945)

  • 21. Selective ablation or isolation of all pulmonary veins in atrial fibrillation -- when and for whom?
    Walczak F; Szumowski L; Urbanek P; Szufladowicz E; Derejko P; Kułakowski P; Baranowski R; Bodalski R; Kepski R; Zagrodzka M; Onish K; Bestry I; Konka M; Kuśnierczyk B; Maryniak A
    Kardiol Pol; 2006 Jan; 64(1):26-35; discussion 36-7. PubMed ID: 16444625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of drugs in pursuit of a rhythm control strategy.
    Kowey PR; Stoenescu ML
    Prog Cardiovasc Dis; 2005; 48(2):139-45. PubMed ID: 16253653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm.
    Cohen M; Naccarelli GV
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):885-90. PubMed ID: 18373600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-antiarrhythmic drugs to prevent atrial fibrillation.
    Moro C; Hernández-Madrid A; Matía R
    Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic drugs management in patients with atrial fibrillation: the new guidelines.
    Haitsma DB; De Groot NM; Jordaens L
    Minerva Cardioangiol; 2011 Apr; 59(2):187-95. PubMed ID: 21368736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review.
    Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ
    Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy for atrial fibrillation.
    Mohammed KS; Kowey PR; Musco S
    Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
    Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
    Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study).
    Bertaglia E; Stabile G; Senatore G; Colella A; Del Greco M; Goessinger H; Lamberti F; Lowe M; Mantovan R; Peters N; Pratola C; Raatikainen P; Turco P; Verlato R
    Europace; 2007 Mar; 9(3):182-5. PubMed ID: 17303627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation: from ion channels to bedside treatment options.
    Singh B
    J Electrocardiol; 2009; 42(6):660-70. PubMed ID: 19520377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation of atrial fibrillation.
    Riley MJ; Marrouche NF
    Curr Probl Cardiol; 2006 May; 31(5):361-90. PubMed ID: 16690376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drug therapy for atrial fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Cardiol Clin; 2014 Nov; 32(4):533-49. PubMed ID: 25443235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of atrial fibrillation: state of the art.
    Camm J
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S2-6. PubMed ID: 16939435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.